MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Volumetry of the olfactory bulbs and tracts in the differential diagnosis of neurodegenerative parkinsonisms

M. Menendez Gonzalez, E. Suárez-Sanmartin, C. García, M. Blázquez Estrada (Mieres, Spain)

Meeting: 2016 International Congress

Abstract Number: 1160

Keywords: Corticobasal degeneration (CBD), Multiple system atrophy(MSA): Anatomy, Olfactory dysfunction, Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Neuroimaging (non-PD)

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: The objective is to assess the use of the volumetry of OB & T as a parameter for distinguishing controls from patients with Parkinson’s disease (PD) multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) and for distinguishing PD from the other diagnostic groups.

Background: Previous studies have shown volumetry of the olfactory bulbs and tracts (OB & T) might be useful in the differential diagnosis of parkinsonisms.

Methods: The study group comprised by 20 patients with PD (stage 1 H&Y), 10 with MSA, 10 with PSP, 5 with corticobasal degeneration CBD and 20 matched controls. All patients were evaluated using UPDRS, DaT-SPECT and brain MRI. We performed volumetry of the OB & T using the software Osrix (Figure 1).

Results: The lowest volume was seen in patients with PD: 208.3 ± 46.3 mm3. The highest volume was seen in controls: 347.4 ± 82.6 mm3. Other groups showed intermediate mean values: MSA: 257.3 ± 44.2 mm3, PSP: 266.2 ± 65.1 mm3, CBD: 331.4 ± 41.7 mm3. When comparing OB & T volumes among the four disease groups and the control group, the mean of PD was different from all other groups (p < 0.05 each) while the mean in controls was only significantly different from PD and MSA.

Conclusions: Our results replicate previous studies and confirm volumetry of OB & T is a parameter in the differential diagnosis PD from other neurodegenerative parkinsonisms. Volumetry of OB & T may also has a role in differentiating early PD from controls.

To cite this abstract in AMA style:

M. Menendez Gonzalez, E. Suárez-Sanmartin, C. García, M. Blázquez Estrada. Volumetry of the olfactory bulbs and tracts in the differential diagnosis of neurodegenerative parkinsonisms [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/volumetry-of-the-olfactory-bulbs-and-tracts-in-the-differential-diagnosis-of-neurodegenerative-parkinsonisms/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/volumetry-of-the-olfactory-bulbs-and-tracts-in-the-differential-diagnosis-of-neurodegenerative-parkinsonisms/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley